Download presentation
Presentation is loading. Please wait.
Published byMai Đào Modified over 5 years ago
1
Opioid Use Disorders: Recognition and Pharmacotherapy Review
Joji Suzuki, MD Director, Division of Addiction Psychiatry Department of Psychiatry, Brigham and Women’s Hospital Assistant Professor of Psychiatry, Harvard Medical School
2
Epidemiology Update: How Did We Get Here?
3
Overview Overview of current state
Deaths caused by drug-related overdoses vs traffic accidents How we got here: three key developments Started in the early 90’s and have a direct impact in the present Non-medical or recreational use Most common opioid sources What happens after recreational use begins?
4
Overview Overview of current state
Deaths caused by drug-related overdoses vs traffic accidents How we got here: three key developments Started in the early 90’s and have a direct impact in the present Non-medical or recreational use Most common opioid sources What happens after recreational use begins?
5
Overview Overview of current state
Deaths caused by drug-related overdoses vs traffic accidents How we got here: three key developments Started in the early 90’s and have a direct impact in the present Non-medical or recreational use Most common opioid sources What happens after recreational use begins?
6
Drug-related overdoses
7
Drug-related overdoses
2014: 28,000 deaths in the US Drug-related overdoses
8
Drug-related overdoses
2014: 28,000 deaths in the US 70 deaths everyday Drug-related overdoses
9
Drug-related overdoses
Traffic accidents 2014: 28,00 deaths in the US 70 deaths everyday Drug-related overdoses
10
Drug overdoses: leading cause of accidental death
Motor vehicle accidents Drug overdoses: leading cause of accidental death Drug induced overdose
11
More deaths from prescription opioids than heroin
12
Overdose deaths/100,000 Opioid sales/10,000
13
How did we get here?
14
“Improve pain management”
Elderly, HIV patients, cancer 1980 1990 2000
15
1990 “Improve pain management” Elderly, HIV patients, cancer
“Opioids? Be careful” 1980 1990 2000
16
1990 “Improve pain management” Elderly, HIV patients, cancer
“Opioids? Be careful” Changes 1980 1990 2000
17
Pain assessment “Fifth vital sign”
18
Greater opioid utilization
Pain assessment Greater opioid utilization “Fifth vital sign”
19
Pain assessment “Fifth vital sign”
Greater opioid utilization “Fifth vital sign” Insufficient training in multimodal treatment
20
Unethical Marketing Unethical Marketing
“Non-addictive version of short-acting oxycodone” Oxycontin (Oxycodone CR) (1996)
21
Unethical Marketing Unethical Marketing No evidence to support claim
“Non-addictive version of short-acting oxycodone” No evidence to support claim Oxycontin (Oxycodone CR) (1996)
22
Non-medical use Unused opioids
23
Non-medical (recreational) use:
Opioids used for purposes other than they were prescribed Self-medicate negative moods Self-medicate insomnia Enjoy euphoria Diversion Snorting
24
Non-medical (recreational) use:
Opioids used for purposes other than they were prescribed Self-medicate negative moods Self-medicate insomnia Enjoy euphoria Diversion Snorting
25
Source of misused prescription opioids
SAMHSA, 2013
26
SAMHSA, 2013
27
Some will be able to stop
Escalation Heroin is much cheaper Physical withdrawal Strong cravings Financially challenging Overdose risk increases dramatically Snorting Injecting
28
Some will be able to stop
Escalation Heroin is much cheaper Physical withdrawal Strong cravings Financially challenging Overdose risk increases dramatically Snorting Injecting
29
Some will be able to stop
Escalation Heroin is much cheaper Physical withdrawal Strong cravings Financially challenging Overdose risk increases dramatically Snorting Injecting
30
Some will be able to stop
Escalation Heroin is much cheaper Physical withdrawal Strong cravings Financially challenging Overdose risk increases dramatically Snorting Injecting
31
Some will be able to stop
Escalation Transition to heroin Physical withdrawal Strong cravings Financially challenging Overdose risk increases dramatically Snorting Injecting
32
Some will be able to stop
Escalation Transition to heroin Physical withdrawal Strong cravings Financially challenging Overdose risk increases dramatically Snorting Injecting
33
Illicitly produced fentanyl
Cheap Widely available Incorporated into heroin Counterfeit tablets Many patients have no idea they are using it
34
Illicitly produced fentanyl
Cheap Widely available Incorporated into heroin Counterfeit tablets Many patients have no idea they are using it
35
Illicitly produced fentanyl
Cheap Widely available Incorporated into heroin Counterfeit tablets Many patients have no idea they are using it
36
Key Points Drug overdoses: now the leading cause of accidental death
Overdose deaths linked to increase in opioid prescriptions Drug diversion Most common source: family and friends Most of these prescriptions come from a single doctor Recreational use Some individuals will escalate Some of them even up to IV heroin
37
Key Points Drug overdoses: now the leading cause of accidental death
Overdose deaths linked to increase in opioid prescriptions Drug diversion Most common source: family and friends Most of these prescriptions come from a single doctor Recreational use Some individuals will escalate Some of them even up to IV heroin
38
Key Points Drug overdoses: now the leading cause of accidental death
Overdose deaths linked to increase in opioid prescriptions Drug diversion Most common source: family and friends Most of these prescriptions come from a single doctor Recreational use Some individuals will escalate Some of them even up to IV heroin
39
Key Points Drug overdoses: now the leading cause of accidental death
Overdose deaths linked to increase in opioid prescriptions Drug diversion Most common source: family and friends Most of these prescriptions come from a single doctor Recreational use Some individuals will escalate Some of them even up to IV heroin
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.